Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page
- Check10 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.5) and indicates that results have been submitted, while previous information about the modernization of ClinicalTrials.gov data ingest and the absence of posted results has been removed.SummaryDifference1%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.2, replacing the previous version v2.16.1. The estimated last update posted has been removed.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to reflect a change in the recruitment status from 'Recruiting' to 'Active, not recruiting', and several important dates related to the study have been modified. Additionally, the contact information for study personnel has been removed.SummaryDifference11%
- Check53 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.